Clinical prediction models in cardiac surgery-associated acute kidney injury: a systematic review and meta-analysis.
8 affiliations
- 1Department of Intensive Care Medicine, Reina Sofia Hospital, Tudela, Navarre, Spain. [email protected].
- 2Public University of Navarre (UPNA), Pamplona, Navarre, Spain. [email protected].
- 3Department of Internal Medicine, Garcia Orcoyen Hospital, Estella, Navarre, Spain.
- 4Faculty of Health Sciences, GRUPAC Research Group, University of La Rioja, La Rioja, Spain.
- 5Methodology Unit, Navarrabiomed-UPNA, Navarre, Spain.
- 6Department of Intensive Care Medicine, University Hospital of Navarre, Pamplona, Navarre, Spain.
- 7Public University of Navarre (UPNA), Pamplona, Navarre, Spain.
- 8Cardiovascular Translational Research, Navarrabiomed (Fundación Miguel Servet); Instituto de Investigación Sanitaria de Navarra (IdiSNA); University Hospital of Navarre, Navarre, Spain.
Abstract
Purpose
Cardiac surgery-associated acute kidney injury (CSA-AKI) is a frequent postoperative complication associated with substantial morbidity and mortality. Clinical prediction models (CPM) may identify high-risk patients enabling targeted preventive interventions and improved outcomes. The objective of the study was to identify available CPMs for the risk of developing CSA-AKI and summarize their performance.Methods
A systematic search of studies published in Pubmed, Scopus, the Chocrane Library and Web of Science was conducted, including studies that developed or validated CPMs for CSA-AKI in adult patients undergoing cardiac surgery with cardiopulmonary bypass. Data were extracted by two independent reviewers. Summary measures of diagnostic performance were calculated when feasible using random-effects models. Calibration and sensitivity analyses were also performed.Results
The pooled incidence of CSA-AKI was 26.3% (95% CI, 26.0-26.4), whereas CSA-AKI requiring renal replacement therapy (CSA-AKI RRT) occurred in 2.2% of patients (95% CI, 2.1-2.2). Among validated CPMs, Thakar 2005 demonstrated the best predictive performance for CSA-AKI RRT: pooled AUC 0.80 (95% CI, 0.77-0.82), sensitivity of 0.87, and a specificity of 0.49 at a threshold of ≥ 3 points. Calibration analyses indicated underestimation of risk. The Mehta 2006 and Wijeysundera 2007 models also demonstrated good discrimination. Discrimination for the prediction of milder stages of CSA-AKI was poorer, but newer models such as the Demirjian 2022 model showed promising performance.Conclusion
Accurate and well-validated CPMs can facilitate risk stratification for CSA-AKI which can influence clinical practice and research. Thakar 2005 demonstrated very good discrimination for predicting CSA-AKI RRT, whereas more validation studies for the prediction of milder stages of CSA-AKI are warranted.
Related
- Real-time Evaluation and Anticipation of Causal disTillation early prediction for cardiac surgery-associated acute kidney injury (REACT-01): study protocol for a single-center prospective randomized clinical trial
- Trial sequential analysis of the efficacy of amino acid and protein therapy in preventing cardiac surgery-associated acute kidney injury: a systematic review and meta-analysis
- Demographic Representation in Clinical Trials for Transthyretin-Associated Cardiac Amyloidosis: A Systematic Review
- Efficacy of Ultrasound-Guided Pectointercostal Fascial Block Versus Control and Alternative Regional Techniques in Cardiac Surgery: A Systematic Review and Meta-Analysis with Dose–Response Analysis
- Association Between Preoperative Anemia and Postoperative Outcomes in Adults Undergoing Cardiac Surgery: A Systematic Review and Meta-analysis
BibTeX
@article{lasaberasain2026clinical,
title = {{Clinical prediction models in cardiac surgery-associated acute kidney injury: a systematic review and meta-analysis.}},
author = {Pablo Lasa-Berasain and Amaia Torrecilla Ugarte and Raúl Juárez-Vela and Berta Ibánez-Beróiz and Aitor Ansotegui Hernández and Rafael Sádaba and Julio Barado Hualde},
journal = {Critical care (London, England)},
year = {2026},
month = oct,
doi = {10.1186/s13054-026-06380-4},
url = {https://europepmc.org/article/MED/42919415},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Clinical prediction models in cardiac surgery-associated acute kidney injury: a systematic review and meta-analysis.
AU - Pablo Lasa-Berasain
AU - Amaia Torrecilla Ugarte
AU - Raúl Juárez-Vela
AU - Berta Ibánez-Beróiz
AU - Aitor Ansotegui Hernández
AU - Rafael Sádaba
AU - Julio Barado Hualde
PY - 2026
DA - 2026/10/15
JO - Critical care (London, England)
DO - 10.1186/s13054-026-06380-4
UR - https://europepmc.org/article/MED/42919415
AB - Purpose Cardiac surgery-associated acute kidney injury (CSA-AKI) is a frequent postoperative complication associated with substantial morbidity and mortality. Clinical prediction models (CPM) may identify high-risk patients enabling targeted preventive interventions and improved outcomes. The objective of the study was to identify available CPMs for the risk of developing CSA-AKI and summarize their performance.Methods A systematic search of studies published in Pubmed, Scopus, the Chocrane Library and Web of Science was conducted, including studies that developed or validated CPMs for CSA-AKI in adult patients undergoing cardiac surgery with cardiopulmonary bypass. Data were extracted by two independent reviewers. Summary measures of diagnostic performance were calculated when feasible using random-effects models. Calibration and sensitivity analyses were also performed.Results The pooled incidence of CSA-AKI was 26.3% (95% CI, 26.0-26.4), whereas CSA-AKI requiring renal replacement therapy (CSA-AKI RRT) occurred in 2.2% of patients (95% CI, 2.1-2.2). Among validated CPMs, Thakar 2005 demonstrated the best predictive performance for CSA-AKI RRT: pooled AUC 0.80 (95% CI, 0.77-0.82), sensitivity of 0.87, and a specificity of 0.49 at a threshold of ≥ 3 points. Calibration analyses indicated underestimation of risk. The Mehta 2006 and Wijeysundera 2007 models also demonstrated good discrimination. Discrimination for the prediction of milder stages of CSA-AKI was poorer, but newer models such as the Demirjian 2022 model showed promising performance.Conclusion Accurate and well-validated CPMs can facilitate risk stratification for CSA-AKI which can influence clinical practice and research. Thakar 2005 demonstrated very good discrimination for predicting CSA-AKI RRT, whereas more validation studies for the prediction of milder stages of CSA-AKI are warranted.
SN - 1364-8535
SN - 1466-609X
ER -